GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (FRA:RME) » Definitions » Cyclically Adjusted Book per Share

ResMed (FRA:RME) Cyclically Adjusted Book per Share : €18.52 (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is ResMed Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

ResMed's adjusted book value per share for the three months ended in Mar. 2024 was €28.999. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €18.52 for the trailing ten years ended in Mar. 2024.

During the past 12 months, ResMed's average Cyclically Adjusted Book Growth Rate was 11.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 9.50% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 8.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of ResMed was 32.00% per year. The lowest was 6.90% per year. And the median was 16.50% per year.

As of today (2024-05-21), ResMed's current stock price is €201.00. ResMed's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €18.52. ResMed's Cyclically Adjusted PB Ratio of today is 10.85.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of ResMed was 19.96. The lowest was 5.26. And the median was 8.59.


ResMed Cyclically Adjusted Book per Share Historical Data

The historical data trend for ResMed's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ResMed Cyclically Adjusted Book per Share Chart

ResMed Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.00 11.82 12.43 16.12 17.11

ResMed Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.36 17.11 18.14 17.71 18.52

Competitive Comparison of ResMed's Cyclically Adjusted Book per Share

For the Medical Instruments & Supplies subindustry, ResMed's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ResMed's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ResMed's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where ResMed's Cyclically Adjusted PB Ratio falls into.



ResMed Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ResMed's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=28.999/131.7762*131.7762
=28.999

Current CPI (Mar. 2024) = 131.7762.

ResMed Quarterly Data

Book Value per Share CPI Adj_Book
201406 9.223 100.560 12.086
201409 9.180 100.428 12.046
201412 9.176 99.070 12.205
201503 10.078 99.621 13.331
201506 10.068 100.684 13.177
201509 9.328 100.392 12.244
201512 9.995 99.792 13.198
201603 10.706 100.470 14.042
201606 10.724 101.688 13.897
201609 11.210 101.861 14.502
201612 11.448 101.863 14.810
201703 12.233 102.862 15.672
201706 12.271 103.349 15.646
201709 12.087 104.136 15.295
201712 11.943 104.011 15.131
201803 11.745 105.290 14.700
201806 12.353 106.317 15.311
201809 11.429 106.507 14.141
201812 12.000 105.998 14.918
201903 12.479 107.251 15.333
201906 12.766 108.070 15.566
201909 13.372 108.329 16.266
201912 14.055 108.420 17.083
202003 14.116 108.902 17.081
202006 15.304 108.767 18.541
202009 15.695 109.815 18.834
202012 16.185 109.897 19.407
202103 15.639 111.754 18.441
202106 16.445 114.631 18.905
202109 17.652 115.734 20.099
202112 19.041 117.630 21.331
202203 20.354 121.301 22.112
202206 21.715 125.017 22.889
202209 23.674 125.227 24.912
202212 24.022 125.222 25.279
202303 24.999 127.348 25.868
202306 25.920 128.729 26.534
202309 27.077 129.860 27.477
202312 27.942 129.419 28.451
202403 28.999 131.776 28.999

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


ResMed  (FRA:RME) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

ResMed's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=201.00/18.52
=10.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of ResMed was 19.96. The lowest was 5.26. And the median was 8.59.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


ResMed Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of ResMed's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


ResMed (FRA:RME) Business Description

Industry
Address
9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

ResMed (FRA:RME) Headlines

No Headlines